ArticleJournal of the American College of Cardiology2021

Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.

Adam Goldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.